Considering the data presented in this study, we suggest that α2β1 integrin expression may be involved in the oncogenic switch of primary tumors to a migratory and metastatic phenotype, while inactivation of α2β1 by bone microenvironmental influences, such as TGF-β and mechanical force, promote tumor-induced bone disease. The gene discussed is TGFB1; the disease is neoplasm.